94
Participants
Start Date
September 30, 2005
Primary Completion Date
June 30, 2009
Study Completion Date
September 30, 2009
S-adenosylmethionine
Alcoholic liver disease patients received drug at dose of 400 mg three times daily for 24 weeks.
Placebo
Alcoholic liver disease patients received identical size and shape sugar pill placebo three times daily for 24 weeks.
University of California, Davis Medical Center, Sacramento
Collaborators (2)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Abbott
INDUSTRY
Joint Clinical Research Center
OTHER
University of Colorado, Denver
OTHER
University of California, Los Angeles
OTHER
University of California, Davis
OTHER